Navigation Links
"Scientific Oktoberfest" Draws the Worldwide Leading Researchers in the Field of Chemical Biology to Munich
Date:9/9/2011

MUNICH, September 9, 2011 /PRNewswire/ --

The "Scientific Oktoberfest" will be this year's meeting point for some of the internationally most distinguished researchers in the field of Chemical Biology. The so-called "CIPSM Fest of Chemical Biology" will be held from the 15th to the 16th of September in the Department of Chemistry of the Ludwig-Maximilians-Universität (LMU) München.

At the two-day conference, 400 researchers from around the world will discuss state-of-the art research in various fields spanning from chemistry to biology and present their latest results in the fight against diseases like cancer or bacterial infections.

Speakers will be:

  • Shankar Balasubramanian
    Dept. of Chemistry, University of Cambridge UK
    "Sequencing Nucleic Acids: A Passage from Chemistry to Science and Medicine"
  • Thomas Carell
    CIPSM at the Dept. of Chemistry, Ludwig-Maximilians-Universität (LMU) München
    "The chemistry of genome development"
  • Chris Chang
    Dept. of Chemistry, UC Berkeley
    "Molecular imaging approaches to understanding metal and redox biology in the brain"
  • Jon Clardy
    Dept. of Chemistry & Chemical Biology, Harvard Med. School, Broad Inst., Harvard University
    "Bacterial Conversations"
  • Benjamin F. Cravatt III
    Dept. of Chemical Physiology, The Skaggs Institute, The Scripps Research Institute
    "Activity-based proteomics: applications for enzyme and inhibitor discovery"
  • François Diederich
    ETH Zürich, Lab. of Organic Chemistry
    "Molecular Recognition at Enzyme Active Sites"
  • Wilfred A. van der Donk
    Dept. of Chemistry, University of Illinois at Urba na-Champaign
    "Posttranslational modifications in natural product biosynthesis"
  • Michael Famulok
    Rheinische Friedrich-Wilhelms-Universität Bonn, Lab. of Chemical Biology
    "Insight into ErbB receptor signaling from a Chemical Biology perspective"
  • Itaru Hamachi
    Dept. of Synthetic Chemistry and Biological Chemistry, Kyoto University
    "Protein labeling and engineering in live cell systems"
  • Julius Rebek
    The Skaggs Institute for Chemical Biology, The Scripps La Jolla
    "Molecular Behavior in Small Spaces"
  • Peter G. Schultz
    The Scripps Research Institute, La Jolla
    "Synthesis at the Interface of Chemistry and Biology"
  • Mitsuhiko Shionoya
    Dept. of Chemistry, University of Tokyo
    "Bio-inspired Molecular Design of Supramolecular Architectures"
  • Hiroshi Sugiyama
    Dept. of Chemistry, Kyoto University
    "Chemical Biology that Controls DNA Structure and Function"
  • Christopher T. Walsh
    Harvard Medical School, Dept. of Chemistry & Chemical Biology, Harvard University
    "Thiazole Peptide Antibiotic Biosynthesis: A Cascade of Posttranslational Modifications"

For more information please visit http://www.cipsm.de/fest/

Contact:
Dr. Oliver Baron
Managing Director of the
Center For Integrated Protein Science Munich (CIPSM) at Ludwig-Maximilians-Universität (LMU) München
Department of Chemistry
81377 Munich
Germany
Tel: +49(0)89-2180-77880
E-mail: oliver.baron@cipsm.de 



'/>"/>
SOURCE Center For Integrated Protein Science Munich (CIPSM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
2. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
3. Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey
4. China Medicine Corporation Voluntarily Withdraws Application for Nasdaq Listing
5. Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin
6. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
10. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
11. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)...  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):